Stock Research for MGNX

Current Price


Latest Update: 2018-03-16 16:00:00

$ 29.7500
$ 29.6800
$ 29.6900

Featured Broker: TradeStation

Get the due diligence for another stock.


MGNX Stock Chart & Research Data

The MGNX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MGNX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


MGNX Due diligence Resources & Stock Charts

The MGNX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MGNX Detailed Price Forecast - CNN Money CNN View MGNX Detailed Summary - Google Finance
Yahoo View MGNX Detailed Summary - Yahoo! Finance Zacks View MGNX Stock Research & Analysis -

Stock Analysis

TradeIdeas View MGNX Trends & Analysis - Trade-Ideas Barrons View MGNX Major Holders - Barrons
NASDAQ View MGNX Call Transcripts - NASDAQ Seeking View MGNX Breaking News & Analysis - Seeking Alpha
Spotlight View MGNX Annual Report - OTC Report View MGNX OTC Short Report -
TradeKing View MGNX Fundamentals - TradeKing Charts View MGNX SEC Filings - Bar Chart
WSJ View Historical Prices for MGNX - The WSJ Morningstar View Performance/Total Return for MGNX - Morningstar
MarketWatch View the Analyst Estimates for MGNX - MarketWatch CNBC View the Earnings History for MGNX - CNBC
StockMarketWatch View the MGNX Earnings - StockMarketWatch MacroAxis View MGNX Buy or Sell Recommendations - MacroAxis
Bullish View the MGNX Bullish Patterns - American Bulls Short Pains View MGNX Short Pain Metrics -

Social Media Mentions

StockTwits View MGNX Stock Mentions - StockTwits PennyStocks View MGNX Stock Mentions - PennyStockTweets
Twitter View MGNX Stock Mentions - Twitter Invest Hub View MGNX Investment Forum News - Investor Hub
Yahoo View MGNX Stock Mentions - Yahoo! Message Board Seeking Alpha View MGNX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for MGNX - Insider Cow View Insider Transactions for MGNX - Insider Cow
CNBC View MGNX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MGNX - OTC Markets
Yahoo View Insider Transactions for MGNX - Yahoo! Finance NASDAQ View Institutional Holdings for MGNX - NASDAQ

Stock Charts

FinViz View MGNX Stock Insight & Charts - StockCharts View MGNX Investment Charts -
BarChart View MGNX Stock Overview & Charts - BarChart Trading View View MGNX User Generated Charts - Trading View

Latest Financial News for MGNX

Consolidated Research: 2018 Summary Expectations for MacroGenics, Radware, Core-Mark Holding, Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp, Atlantic Capital Bancshares, and Alliance Resource Partners — Fundamental Analysis, Key Performance Indications
Posted on Friday March 16, 2018

NEW YORK, NY, March 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders ...

MacroGenics to Present at Cowen Health Care Conference
Posted on Friday March 09, 2018

Rockville, MD, March 09, 2018--. MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment ...

MacroGenics tops 4Q profit forecasts
Posted on Tuesday February 27, 2018

The Rockville, Maryland-based company said it had profit of $2.80 per share. The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research ...

MacroGenics Provides Update on Corporate Progress and 2017 Financial Results
Posted on Tuesday February 27, 2018

ROCKVILLE, Md., Feb. 27, 2018-- MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of ...

Warning: DOMDocument::load( failed to open stream: HTTP request failed! HTTP/1.0 404 Not Found in /home/allsites/ on line 494

Warning: DOMDocument::load(): I/O warning : failed to load external entity "" in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.